The clearest coverage concentration is market-trends: 2 of 3 stories, with the rest divided among 1 other category. Of the tracked stories, 1 of 3 also mention Alphabet, the most common co-covered peer. Source depth averages 2.7 original sources per story, versus 3.4 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Target
The clearest coverage concentration is market-trends: 2 of 3 stories, with the rest divided among 1 other category. Of the tracked stories, 1 of 3 also mention Alphabet, the most common co-covered peer. Source depth averages 2.7 original sources per story, versus 3.4 across the same-window beat baseline. The 175-day window averages about 0.1 stories each week. Their average consequence score of 6.3 runs above the beat's 6 for that window. We currently track 3 Healthcare stories that mention Target, published between February 27, 2026 and August 20, 2026.
Stories tracked
3
Per week
0.1
Sources per story
2.7
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 1058 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Target. Shared-story counts are live from our verified record — not editorial picks.
Moderna's mRNA cancer therapy readout sent its shares up as much as 177%, driving a 2.9% record gain in the S&P 500 healthcare sector amid easing Treasury yields. The rally lifted peers including Merck, BioNTech and Novavax, but macro rate worries persist.
Colorado lawmakers have introduced a bill to impose fees on corporations with over 500 employees whose workers rely on state Medicaid. The legislation aims to recoup public costs for healthcare coverage that proponents argue should be provided by profitable large employers.
Target has announced a landmark policy to exclusively sell cereals free of synthetic colors, marking a significant shift in its grocery strategy. This move aligns with increasing consumer demand for natural ingredients and sets a new health-conscious standard for mass-market retailers.